Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Vivo Opportunity Fund Holdings, L.P.'s stake in Terns Pharmaceuticals, Inc. fell to 2.50% (Schedule 13G/A)
Event Jan 31, 2025 · Filed Feb 13, 2026
Vivo Opportunity Fund Holdings, L.P.'s stake in Terns Pharmaceuticals, Inc. fell to 2.50%, 2,700,615 shares, as a passive investor on Jan 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 2.50%
- Shares
- 2,700,615
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Capital Fund VIII, L.P. | 0.90% | 966,461 |
| Vivo Capital Surplus Fund VIII, L.P. | 0.10% | 133,415 |
| Vivo Capital VIII, LLC | 1.00% | 1,099,876 |
| Vivo Opportunity Fund Holdings, L.P. | 2.50% | 2,700,615 |
| Vivo Opportunity, LLC | 2.50% | 2,700,615 |
| Vivo Opportunity Cayman Fund, L.P. | 0.20% | 241,652 |
| Vivo Opportunity Cayman, LLC | 0.20% | 241,652 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Vivo Opportunity, LLC
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026